Enovis Climbs on Swing to 3Q Profit, Higher Sales

By Connor HartShares of Enovis gained after the medical-technology company swung to a profit and logged higher sales in the recent quarter, prompting it to raise its full-year outlook.The stock rose 12%, to $27.44, midday Thursday and is up roughly 3% year-to-date.The company before the bell report…